See All Slides - tctmd.com

Slides

Presentation TCT 2013

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

Presenter: Andrew Farb

October 28, 2013

Presentation TCT 2013

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Presenter: Finn Gustafsson

October 28, 2013

Presentation TCT 2013

Surgical Approaches to the Spectrum of Mitral Valve Regurgitant Pathologies: Which Techniques Work?

Presenter: Patrick McCarthy

October 28, 2013

Presentation TCT 2013

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Presenter: Alex Powell

October 28, 2013

Presentation TCT 2013

Didactic(5)

Presenter: Lynne Hinterbuchner

October 28, 2013

Presentation TCT 2013

The Hybrid Approach IV: When to go Retrograde and to Select Septals

Presenter: Julian Strange

October 28, 2013

Presentation TCT 2013

Direct Annuloplasty: Mitralign Design Iterations and Clinical Results

Presenter: Scott Lim

October 28, 2013

Presentation TCT 2013

Case Presentation: Procedural and Follow-Up Results

Presenter: Junjie Zhang

October 28, 2013

Presentation TCT 2013

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Presenter: Bo Lagerqvist

October 28, 2013

Advertisement

Slides

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Surgical Approaches to the Spectrum of Mitral Valve Regurgitant Pathologies: Which Techniques Work?

Monitoring Graft Adequacy and Possible Causes of Graft Failure

Didactic(5)

The Hybrid Approach IV: When to go Retrograde and to Select Septals

Direct Annuloplasty: Mitralign Design Iterations and Clinical Results

Case Presentation: Procedural and Follow-Up Results

The Case for Dedicated Bifurcation Stents; Device and Regulatory Landscape; and Anticipation of the Pivotal Tryton Results

Latest Data from SCAAR and SWEDEHEART: Can a Nationwide Registry Tease Out Important Findings Hidden from Randomized Trials?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content